VBS: Vanta Biosciences arm signs Rs 29 crore deal with Emcure Pharma

The official spokesperson of Emcure Pharmaceuticals Ltd. added, "Service-efficiency, confidentiality and belief in the team in-charge of execution are important factors for selecting the service providers for carrying out our bio-analytical and bio-equivalence studies and we believe that Vayam has the capabilities." New Delhi: Vanta Bioscience Limited has recently announced that its step-down subsidiary 'Vayam Research SolutionsThe post Vanta Biosciences arm signs Rs 29 crore deal with Emcure Pharma appeared first on Business | Medical Dialogues.